[Treatment of xerophthalmia by transplantation of autologous vascularized submandibular gland]

Zhonghua Yi Xue Za Zhi. 2002 Feb 25;82(4):244-6.
[Article in Chinese]

Abstract

Objective: To investigate the feasibility of treatment of xerophthalmia by transplantation of autologous vascularized submandibular gland (SMG).

Methods: The SMGs of 19 patients with severe keratoconjunctivitis were transferred to their temporal region by microsurgery. The arteries and veins of the SMGs were anastomosed to the super-temporal arteries and veins, the SMG ducts were implanted into the conjunctival fornix of the eye. The saliva secreted by the SMG was used as the substitute of tear.

Results: The transplantation succeeded in 14 patients and failed in 4. Follow up lastred for 3 months to 2 years. The symptom of corneal xerosis disappeared, the symptoms of photophobia and anemophobia were alleviated, and artificial tear substitutes were not used any more. Epiphora appeared in 4 cases and disappeared after partial resection of the transplanted gland. Atresia of orifice occurred in one case and was cured by reconstruction of the duct.

Conclusion: Transplantation of autologous vascularized SMG is effective in treating severe keratoconjunctivitis sicca.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Submandibular Gland / blood supply
  • Submandibular Gland / transplantation*
  • Transplantation, Autologous
  • Xerophthalmia / surgery*